1,1'-Carbonyldiimidazole → N-(1-(4-cyanophenyl)-3,3-dimethyl-1-oxobutan-2-yl)-4-(6-methylpyridin-2-yl)piperazine-1-carboxamide
反応式
Cl.[NH2:2][CH:3]([C:14]([CH3:17])([CH3:16])[CH3:15])[C:4]([C:6]1[CH:13]=[CH:12][C:9]([C:10]#[N:11])=[CH:8][CH:7]=1)=[O:5].C1N=CN([C:23](N2C=NC=C2)=[O:24])C=1.[CH3:30][C:31]1[N:36]=[C:35]([N:37]2[CH2:42][CH2:41][NH:40][CH2:39][CH2:38]2)[CH:34]=[CH:33][CH:32]=1>CC#N>[C:10]([C:9]1[CH:12]=[CH:13][C:6]([C:4](=[O:5])[CH:3]([NH:2][C:23]([N:40]2[CH2:41][CH2:42][N:37]([C:35]3[CH:34]=[CH:33][CH:32]=[C:31]([CH3:30])[N:36]=3)[CH2:38][CH2:39]2)=[O:24])[C:14]([CH3:17])([CH3:16])[CH3:15])=[CH:7][CH:8]=1)#[N:11]参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
4-(2-Amino-3,3-dimethylbutanoyl)benzonitrile hydrochloride (Example 3, 50 mg, 0.23 mmol) was added to a solution of CDI (112 mg, 0.69 mmol) and TEA (0.035 mL, 0.25 mmol) in MeCN (5 mL). The reaction mixture was stirred at rt for 90 minutes before 1-(6-methylpyridin-2-yl)piperazine (CAS 55745-89-6, 205 mg, 1.16 mmol) was added. The mixture was stirred for 1 h and the solvent was evaporated under reduced pressure. The product was dissolved in methanol, filtered and purified by prep. HPLC yielding N-(1-(4-cyanophenyl)-3,3-dimethyl-1-oxobutan-2-yl)-4-(6-methylpyridin-2-yl)piperazine-1-carboxamide (36.3 mg, 37%).
後処理
- additionwas added
- customthe solvent was evaporated under reduced pressure
- dissolutionThe product was dissolved in methanol
- filtrationfiltered
- custompurified by prep
出典と根拠
- ORDレコード
- ord-dd590cdc668e4a9d9ab05f80eed7ff09
- 出典データセット
- uspto-grants-2014_10
- 特許番号
- US08859556B2
反応ノート
読み込み中…